Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-017534
Filing Date
2022-06-22
Accepted
2022-06-22 20:05:51
Documents
2
Period of Report
2022-06-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2837
2 ex-24.htm EX-24 10309
  Complete submission text file 0001493152-22-017534.txt   14613
Mailing Address 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108
Business Address 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108 (734) 369-2555
Zomedica Corp. (Issuer) CIK: 0001684144 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZOMEDICA CORP 100 PHOENIX DRIVE, SUITE 125 ANN ARBOR MI 48018
Business Address
DeHaan-Fullerton Karen (Reporting) CIK: 0001934689 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38298 | Film No.: 221033325